Erigeron breviscapus
Erigeron breviscapus · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Erigeron breviscapus is a significant plant in Chinese medicine, commonly prepared as the extract known as Dengzhanxixin (DZXX). Utilizing various parts including the leaf, flower, root, and stem, this botanical source is rich in bioactive compounds such as scutellarin, flavonoids, breviscapine, and chlorogenic acid. These chemical constituents provide essential antioxidant, hypocholesterolemic, and neuroprotective activities. Consequently, the plant is frequently employed to treat serious medical conditions like cardiovascular diseases and cerebrovascular diseases. Its therapeutic potential is particularly vital in managing clinical challenges such as cerebral ischemia.
- Synonyms
- Erigeron Dielsii · Erigeron Praecox · 4 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf · Flower
Classification
Synonyms
Erigeron breviscapus is a botanical species characterized by several recognized taxonomic synonyms. Within its complex classification, it has been identified under the name Aster breviscapus in older or alternative records. The plant also encompasses various specialized forms, including the varieties alboradiatus, leucanthus, and tibeticus. Furthermore, historical botanical studies have occasionally referred to this species as Erigeron dielsii. Understanding these diverse names is essential for researchers navigating the intricate nomenclature of this plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erigeron breviscapus belongs to the vast kingdom Plantae, representing the diverse world of multicellular photosynthetic organisms. Within this kingdom, the species is classified under the class Equisetopsida, marking its place among the vascular plants. It further falls into the order Asterales, a group known for its distinct floral structures. This plant is a member of the extensive genus Erigeron, which contains many specialized species. Ultimately, it is most recognized as a part of the Asteraceae family, making it a relative of the well-known daisy.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Erigeron |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erigeron breviscapus is a plant species primarily found within the Asia-Temperate regions. Its natural distribution is concentrated across various parts of China, including the South-Central provinces. The species also thrives throughout the Southeast regions of the country. Furthermore, its presence extends into the high-altitude landscapes of Tibet. These diverse locations highlight the plant's ability to inhabit different environmental niches across the Asian continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erigeron breviscapus grows in a distinct herb form, characterized by its delicate structure. This plant is entirely self-supporting, allowing it to maintain its upright position within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Erigeron breviscapus is a highly valued medicinal plant recognized for its diverse and potent pharmacological properties. Research highlights its significant antioxidant activity, particularly through its ability to scavenge free radicals like hydroxyl radicals. The plant also demonstrates notable hypocholesterolemic effects, with its active component scutellarin helping to reduce serum total cholesterol and mitigate atherogenic risks. Furthermore, Erigeron breviscapus exhibits important neuroprotective qualities that can help decrease neuronal injury in the central nervous system. These combined therapeutic benefits support its long-standing traditional use in treating complex cardiovascular and cerebrovascular conditions.
Compounds
Erigeron breviscapus is a traditional Chinese medicinal plant recognized for its rich concentration of bioactive flavonoids. Among its most significant chemical constituents are scutellarin and scutellarein, which serve as major active ingredients in its therapeutic applications. The plant also contains chlorogenic acid, a compound frequently studied alongside other metabolites to understand its pharmacokinetic profile. Furthermore, the medicinal value of the herb is closely linked to the presence of breviscapine, a flavonoid extract used to treat various cardiovascular and cerebrovascular diseases. Together, these diverse chemical relationships underscore the complex biological importance of this species in modern pharmacology.
Conditions
Erigeron breviscapus treats cardiovascular diseases and cerebrovascular diseases, serving as a vital component in traditional Chinese medicine. This plant is widely utilized for the clinical treatment of cardio- and cerebrovascular diseases due to its rich flavonoid content. Research specifically highlights that Erigeron breviscapus treats cerebrovascular disease through various bioactive compounds like scutellarin. Furthermore, studies demonstrate that Erigeron breviscapus treats cerebral ischemia by improving neuronal metabolism and reestablishing blood circulation. These diverse medicinal applications underscore the plant's significant therapeutic value in managing critical vascular and neurological conditions.
Preparations
Erigeron breviscapus is prepared as an extract used to study anticoagulation and pharmacokinetic properties. This plant is also prepared as Breviscapine, a commercially produced extract utilized for its antioxidant activities in treating ischemic diseases. As a traditional Chinese medicine, the plant serves as the source for various therapeutic applications in clinical settings. It is prepared as Dengzhanxixin (DZXX), a medicinal material containing main active components like scutellarin used to treat cerebrovascular diseases. Additionally, Erigeron breviscapus is prepared as EBTF, a total flavonoid fraction that demonstrates significant hydroxyl radical scavenging capacity.
Parts used
Erigeron breviscapus is a significant medicinal plant characterized by various anatomical structures including the leaf, flower, stem, and root. Scientific research indicates that the concentration of the active compound scutellarin varies significantly across these different plant parts. The highest levels of scutellarin are found in the leaves, followed by the flowers and stems, while the compound is notably absent in the roots. Additionally, studies on gene expression show that the CHS gene is most active in the leaves, far exceeding expression levels in the flower, stem, or root. Understanding how these specific parts contribute to the plant's chemical profile is essential for optimizing its pharmacological use.